Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery

Area of Science:

• Biochemistry
• Materials Science
• Nanotechnology

Background:

• Gene therapy holds significant therapeutic potential but faces challenges in effective and safe delivery vectors.
• Developing non-viral vectors with high transfection efficiency and low toxicity is crucial for clinical translation.

Purpose of the Study:

• To evaluate polycationic amphiphilic cyclodextrins as novel therapeutic gene vectors for in vivo applications.
• To identify an optimal cyclodextrin structure for efficient and safe gene delivery.

Main Methods:

• Synthesis and characterization of polycationic amphiphilic cyclodextrins with varying functional groups and chain lengths.
• In vitro transfection studies in HeLa and HepG2 cell lines to assess efficiency and toxicity.
• In vivo gene delivery experiments in mice using a therapeutic gene plasmid.

Main Results:

• A tetradecacationic cyclodextrin structure with specific amino and thioureido groups and hexanoyl chains proved optimal.
• Efficient serum-resistant transfection was achieved in vitro, comparable to branched poly(ethyleneimine) with reduced toxicity.
• In vivo studies demonstrated high liver transfection levels after systemic injection, avoiding lung sequestration and exhibiting low toxicity.

Conclusions:

• Polycationic amphiphilic cyclodextrins are effective and safe gene delivery vectors for in vivo applications.
• The optimized cyclodextrin formulation overcomes common delivery barriers, showing promise for therapeutic gene therapy.
• Further research into these cyclodextrin-based nanocarriers could advance non-viral gene delivery strategies.